CATALYS PACIFIC
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. Founded in 2019, the firm's mission is to focus on providing healthcare solutions for patients worldwide through the creation of and investment in bioventure companies. Catalys Pacific is led by a global team versed in working closely with its partners in academia, biotech, venture capital and the pharmaceutical industry in Japan and worldwide. The firm maintains offices in Tokyo and Kanagawa (Shonan Health Innovation Park), Japan and in Seattle, Washington.
CATALYS PACIFIC
Social Links:
Industry:
Biotechnology Life Science Pharmaceutical
Founded:
2019-01-01
Status:
Active
Email Addresses:
[email protected]
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
BioAdvance
BioAdvance is a Pennsylvania-based venture capital firm that provides funding to life sciences startups.
Current Advisors List
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-08 | Mineralys Therapeutics | Catalys Pacific investment in Series B - Mineralys Therapeutics | 118 M USD |
| 2022-03-28 | Aculys Pharma | Catalys Pacific investment in Series B - Aculys Pharma | 2.8 B JPY |
| 2021-10-28 | Aculys Pharma | Catalys Pacific investment in Series A - Aculys Pharma | 6.8 B JPY |
| 2021-09-08 | HilleVax | Catalys Pacific investment in Venture Round - HilleVax | 135 M USD |
| 2021-06-22 | Pathalys Pharma | Catalys Pacific investment in Seed Round - Pathalys Pharma | 11 M USD |
| 2021-04-06 | Mineralys Therapeutics | Catalys Pacific investment in Seed Round - Mineralys Therapeutics | 4 M USD |
| 2021-04-06 | Mineralys Therapeutics | Catalys Pacific investment in Series A - Mineralys Therapeutics | 40 M USD |
| 2020-07-16 | Exalys Therapeutics | Catalys Pacific investment in Series A - Exalys Therapeutics | 15 M USD |
| 2019-05-15 | Phathom Pharmaceuticals | Catalys Pacific investment in Private Equity Round - Phathom Pharmaceuticals | 90 M USD |
More informations about "Catalys Pacific"
Catalys Pacific - mtec-sc.org
Catalys Pacific is a venture capital firm focused on creating and developing bespoke biotech companies through transpacific partnerships. With a strong presence in both Japan and the …See details»
Catalys Pacific - Crunchbase Investor Profile
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. Founded in 2019, the firm's mission is to focus on providing healthcare solutions for patients worldwide through the creation of …See details»
Catalys Pacific | Harvard Business Publishing Education
Catalys Pacific's early challenges prompt students to evaluate what features of the business environment are critical for venture capital generally, and venture creation funds specifically, to …See details»
People - Catalys Pacific
Catalys Pacific’s “on-the-ground” investment team brings together dedicated R&D experts & advisors, local sourcing partners & institutions combined with broad syndicate relationships. …See details»
Catalys Pacific - The Org
Catalys Pacific begins operations as one of Japanʼs largest life sciences-focused investment firms. The firmʼs mission is to provide solutions to unmet medical needs for patients worldwide by creating and investing in companies that drive …See details»
Catalys Pacific - VC Firm Profile - Gaebler.com Venture Capital …
Aug 20, 2024 Leveraging its networks in academia, biotech, venture capital and the pharmaceutical industry, Catalys Pacific has assembled a group of Strategic and Preferred …See details»
Catalys Pacific - Funding, Financials, Valuation & Investors
Catalys Pacific is an independent venture capital firm focusing on early-stage investments in life sciences. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Catalys Pacific - Case - Faculty & Research - Harvard Business School
In 2019, BT Slingsby founds Catalys Pacific, the first biotech “venture creation” fund in Tokyo. After convincing some of the biggest Japanese pharmaceutical firms to invest, BT hopes the …See details»
Catalys Pacific, LLC | Qodeo
Raising the Fund, Deploying into New & Portfolio Companies, Exiting my Portfolio, Secondary Sale of Fund and End of Fund LifeSee details»
Catalys Pacific - venturecapitalarchive.com
Apr 4, 2025 Catalys Pacific is a venture Capital firm that is dedicated to transforming life sciences innovation. The firm focuses on creating and investing in global biotech companies, …See details»
Contact - Catalys Pacific
Tokyo VORT Minamiaoyama III 4F 8-14, Minami-Aoyama 3-chome Minato-ku, Tokyo 107-0062, JapanSee details»
Catalys Pacific - Contacts, Employees, Board Members
Catalys Pacific has 6 current employee profiles, including Associate Reika Okada. Catalys Pacific has 7 board members and advisors, including Jon Congleton. Contacts. Edit Contacts Section. …See details»
Perspectives - Catalys Pacific
Jun 19, 2019 Domain Associates and Catalys Pacific Launch Exalys Therapeutics to Develop Portfolio of Next-Generation EP4 Antagonists. June 19, 2020. Catalys Pacific Strengthens …See details»
Charter - Catalys Pacific
Improving patient lives worldwide by driving impact and innovation in healthcare and contributing to advancements in life sciences.See details»
Catalys Pacific - Investments, Portfolio & Company Exits
Catalys Pacific has invested in Phathom Pharmaceuticals on Aug 20, 2024. This investment - Private Equity Round - Phathom Pharmaceuticals - was valued at . obfuscated. obfuscated. …See details»
Creations - Catalys Pacific
We are an “on-the-ground” investment team with dedicated R&D experts and advisors, local sourcing partners and institutions combined with broad syndicate relationships.See details»
Mineralys - Catalys Pacific
The value proposition by Catalys Pacific of creating a dedicated new company in the US to develop MLS-101 was extremely attractive. The US is the world’s largest pharmaceutical …See details»
UNAIDS, WHO support DOH’s call for urgent action as the …
9 hours ago The Joint United Nations Programme on HIV/AIDS (UNAIDS) and the World Health Organization (WHO) support the Philippine Government, its partners, and communities in their …See details»
Nato chief says it must build Indo-Pacific ties to meet China’s ...
1 day ago The head of the North Atlantic Treaty Organization warned on Monday that China’s growing military and its close alignment with Russia, Iran and North Korea meant that Nato …See details»
Catalys Pacific - venturecapitalarchive.com
Catalys Pacific is a venture capital firm that is dedicated to transforming life sciences innovation. The firm focuses on creating and investing in global biotech companies, particularly with …See details»